CAS: 1190217-35-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | ASP 7663 REF: IN-DA01E011CAS: 1190217-35-6 | 98% | To inquire | Wed 11 Dec 24 |
 | ASP7663 REF: TM-T8410CAS: 1190217-35-6 | 98.11% | 39.00 €~486.00 € | Wed 18 Dec 24 |
 | ASP 7663 REF: 3D-FA141821CAS: 1190217-35-6 | Min. 95% | To inquire | Wed 22 Jan 25 |
Ref: IN-DA01E011
| 5mg | 196.00 € | ||
| 10mg | 292.00 € | ||
| 25mg | 536.00 € | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
ASP7663
CAS:1190217-35-6
ASP7663 is a TRPA1 Receptor Agonist and exhibiting an abdominal analgesic effect in vivo.
Formula:
C14H14FNO3
Purity:
98.11%
Color and Shape:
Solid
Molecular weight:
263.26
Ref: TM-T8410
| 1mg | 39.00 € | ||
| 5mg | 81.00 € | ||
| 10mg | 109.00 € | ||
| 25mg | 213.00 € | ||
| 50mg | 323.00 € | ||
| 100mg | 486.00 € | ||
| 1mL*10mM (DMSO) | 89.00 € |
Estimated delivery in United States, on Wednesday 18 Dec 2024
ASP 7663
CAS:1190217-35-6
ASP 7663 is a new drug that has been developed for the treatment of chronic …
Formula:
C14H14FNO3
Purity:
Min. 95%
Molecular weight:
263.26 g/mol
Ref: 3D-FA141821
| 2mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 22 Jan 2025
